1-(2-Fluoro-4-(methylsulfonyl)phenyl)piperazine

Catalog No. :
ACQAUN482
CAS No. :
845616-10-6
Molecular Formula :
C11H15FN2O2S
Molecular Weight :
258.32

IUPAC Name:1-(2-fluoro-4-(methylsulfonyl)phenyl)piperazine

1-(2-Fluoro-4-(methylsulfonyl)phenyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$90.00Login to see priceIn stockInquiry
5g98%$348.00Login to see priceIn stockInquiry
25g98%$1336.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Fluoro-4-(methylsulfonyl)phenyl)piperazine
IUPAC Name1-(2-fluoro-4-(methylsulfonyl)phenyl)piperazine
MDL No.MFCD03648602
Molecular FormulaC11H15FN2O2S
Molecular Weight258.32
SMILESO=S(C1=CC=C(N2CCNCC2)C(F)=C1)(C)=O
InChI KeyCMYAOPCJWBOQNZ-UHFFFAOYSA-N
Synonym2-Fluoro-4-(piperazin-1-yl)phenyl methyl sulphone;1-[2-Fluoro-4-(methylsulphonyl)phenyl]piperazine 95+%;Piperazine,1-[2-fluoro-4-(methylsulfonyl)phenyl]-;1-(2-Fluoro-4-(methylsulfonyl)phenyl)piperazine - [F92731]
CAS No.845616-10-6
PubChem CID2782730

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQAUN482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQAUN482 route product structure diagram
    ACQAUN482845616-10-6 In Stock
Inquiry

2. ACQAUN482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQAUN482 route product structure diagram
    ACQAUN482845616-10-6 In Stock
Inquiry

Comments (0)